Echo Street Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-11,830
Closed -$606K 578
2022
Q4
$606K Buy
11,830
+3,265
+38% +$157K 0.01% 242
2022
Q3
$375K Buy
+8,565
New +$416K ﹤0.01% 348
2022
Q2
Sell
-20,513
Closed -$1.06M 674
2022
Q1
$1.06M Sell
20,513
-10,711
-34% -$556K 0.01% 212
2021
Q4
$1.84M Sell
31,224
-3,826
-11% -$190K 0.01% 165
2021
Q3
$1.51M Buy
35,050
+23,165
+195% +$1.03M 0.01% 176
2021
Q2
$465K Buy
11,885
+4,680
+65% +$182K ﹤0.01% 389
2021
Q1
$261K Sell
7,205
-5,968
-45% -$212K ﹤0.01% 445
2020
Q4
$485K Buy
+13,173
New +$483K ﹤0.01% 259

Other funds holding PFE

Echo Street Capital Management's PFE Position: Q1 2023 in Review

Echo Street Capital Management sold out of Pfizer (PFE) in Q1 2023, closing a stake of 11,830 shares — an estimated $606K sold.

Echo Street Capital Management first reported a position in PFE in Q4 2020 and held it in 8 quarters. The position peaked at $1.84M in Q4 2021. 3,102 funds tracked by Wall St. Rank hold PFE as of Q1 2023.

  • Echo Street Capital Management reported no remaining Pfizer position as of Q1 2023 after selling out during the quarter.
  • Echo Street Capital Management sold 11,830 Pfizer shares in Q1 2023, an estimated $606K.
  • Echo Street Capital Management first reported a position in Pfizer in Q4 2020 and held it in 8 quarters.
  • Echo Street Capital Management's Pfizer position peaked at $1.84M in Q4 2021.
  • 3,102 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.

Based on Echo Street Capital Management's 13F filing for Q1 2023, filed 15 May 2023.